SARS Diagnostics Workshop July 14 Would Facilitate Lab Resource Exchange
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center sees the severe acute respiratory syndrome outbreak as an opportunity to address the scientific challenges of developing new diagnostics when a disease remains ill-defined